Philippe Romagnoli

Philippe Romagnoli discloses dealings in Omrix Biopharmaceuticals, Inc. to SEC (Form 4). In total, 6 filings cover trades dated from 20 December 2006 to 4 September 2008.

On the open market, the record shows 3 purchases worth €240k and 1 sale worth €1.5M. Sales outweigh purchases by €1.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants. So far in 2008, the count stands at 3 purchases and no sales.

In size, the median ticket on the buying side is €67k.

The newest entry dates from 5 September 2008: a share grant, in Omrix Biopharmaceuticals, Inc. The clock since the last published purchase (26 March 2008) now reads 6,786 days. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.